Your browser doesn't support javascript.
loading
A Src inhibitor regulates the cell cycle of human pluripotent stem cells and improves directed differentiation.
Chetty, Sundari; Engquist, Elise N; Mehanna, Elie; Lui, Kathy O; Tsankov, Alexander M; Melton, Douglas A.
Afiliação
  • Chetty S; Department of Stem Cell and Regenerative Biology, Harvard Stem Cell Institute, Cambridge, MA 02138 schetty@mcb.harvard.edu dmelton@harvard.edu.
  • Engquist EN; Department of Stem Cell and Regenerative Biology, Harvard Stem Cell Institute, Cambridge, MA 02138.
  • Mehanna E; Department of Stem Cell and Regenerative Biology, Harvard Stem Cell Institute, Cambridge, MA 02138.
  • Lui KO; Department of Stem Cell and Regenerative Biology, Harvard Stem Cell Institute, Cambridge, MA 02138.
  • Tsankov AM; Department of Stem Cell and Regenerative Biology, Harvard Stem Cell Institute, Cambridge, MA 02138 Broad Institute of MIT and Harvard, Cambridge, MA 02142.
  • Melton DA; Department of Stem Cell and Regenerative Biology, Harvard Stem Cell Institute, Cambridge, MA 02138 Howard Hughes Medical Institute, Harvard University, Cambridge, MA 02138 schetty@mcb.harvard.edu dmelton@harvard.edu.
J Cell Biol ; 210(7): 1257-68, 2015 Sep 28.
Article em En | MEDLINE | ID: mdl-26416968
Driving human pluripotent stem cells (hPSCs) into specific lineages is an inefficient and challenging process. We show that a potent Src inhibitor, PP1, regulates expression of genes involved in the G1 to S phase transition of the cell cycle, activates proteins in the retinoblastoma family, and subsequently increases the differentiation propensities of hPSCs into all three germ layers. We further demonstrate that genetic suppression of Src regulates the activity of the retinoblastoma protein and enhances the differentiation potential of hPSCs across all germ layers. These positive effects extend beyond the initial germ layer specification and enable efficient differentiation at subsequent stages of differentiation.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazóis / Pirimidinas / Diferenciação Celular / Células-Tronco Pluripotentes / Inibidores de Proteínas Quinases Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazóis / Pirimidinas / Diferenciação Celular / Células-Tronco Pluripotentes / Inibidores de Proteínas Quinases Idioma: En Ano de publicação: 2015 Tipo de documento: Article